BioAge Labs
BIOA
58 hedge funds and large institutions have $431M invested in BioAge Labs in 2024 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1,204.05% more ownership
Funds ownership: 0% → 1,204.05% (+1,204%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AH Capital Management
Menlo Park,
California
|
+$60.4M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$46.2M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$44.3M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$32.7M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$29.2M |
Top Sellers
BIOA Hedge Fund Activity: Q3 2024 in Review
58 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q3 2024, worth a combined $431M.
Buyers outnumbered sellers: 58 funds opened new BIOA positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AH Capital Management, opening a new position worth an estimated $60.4M.
- 58 institutional investors held BioAge Labs (BIOA) as of Q3 2024, up from 0 in Q2 2024.
- Funds reported $431M of BioAge Labs stock for Q3 2024.
- 58 funds opened new BioAge Labs positions in Q3 2024 and 0 closed out, a net change of +58 holders.
- The largest BioAge Labs buyer in Q3 2024 was AH Capital Management, an estimated $60.4M added.
Based on aggregated 13F filings for Q3 2024.